Minoxidil is probably the most widely used hair loss product in the world, and almost everyone who starts noticing a receding hairline has tried it. It is also one of the most misunderstood: some people quit after three weeks because "more hair is falling out", and others use it for years on an area where there is nothing left to rescue.
This guide explains how it works, how long it takes, what side effects it has, what changes with the oral version and, above all, when it stops being enough. It isn't a prescription; it's what we would explain in a consultation.
Quick answer
- Minoxidil works, but not for everyone or everywhere. It thickens and lengthens hair that is weakening; it does not grow hair where the follicle is already gone.
- 5% outperforms 2% in men. In a 48-week trial, 5% produced 45% more regrowth than 2%. In women, 5% also beat placebo.
- It takes patience. Trials measure results at 4 months and, above all, at one year. You can't judge it before 6 months.
- Some extra shedding at the start is common. It is usually read as hairs that were about to fall out cycling early; it's not a reason to quit without talking to your doctor.
- It works while you use it. If you stop, the gains tend to be lost over the following months.
- Low-dose oral minoxidil is an off-label use some dermatologists prescribe. In the only head-to-head trial in men it was not superior to topical on the main outcome, and it has systemic effects that need monitoring.
- When the area is already smooth, minoxidil isn't enough. At that point the way to get hair back is a hair transplant, and minoxidil can keep protecting the hair you still have.
What minoxidil does (and doesn't do)
Minoxidil started life as an oral drug for high blood pressure. Hair growth was a side effect that turned into a treatment. How it acts on the follicle is still not fully understood: in animal studies it shortens the resting phase and brings forward the growth phase, and it probably also prolongs that growth phase and enlarges the follicle (Messenger and Rundegren, 2004).
The practical consequence: minoxidil does not act on DHT, the hormone that shrinks follicles in androgenetic alopecia. It stimulates the follicle, but it doesn't stop the cause. That is why it is often combined with a DHT blocker, as we explain in our guide to the treatments that actually slow androgenetic alopecia.
For the same reason it has a clear limit: it needs a living follicle to act on. On a patch that has been smooth and shiny for years, there is no follicle left to stimulate.
What the studies show
| Study | Who | What it compared | Main result |
|---|---|---|---|
| Olsen et al., 2002 | 393 men, 48 weeks | 5% vs 2% solution vs placebo, twice daily | 5% beat both, with an earlier response; more itching and irritation with 5% |
| Lucky et al., 2004 | 381 women, 48 weeks | 5% vs 2% solution vs placebo | 5% beat placebo on all three primary measures; more facial hair with 5% |
| Olsen et al., 2007 | 352 men, 16 weeks | Propylene glycol-free 5% foam vs placebo | Higher hair counts than placebo; well tolerated over a year |
| Blume-Peytavi et al., 2011 | 113 women, 24 weeks | 5% foam once daily vs 2% solution twice daily | Equivalent results, with less itching and flaking on foam |
| Olsen et al., 1990 | 31 men, 4.5 to 5 years | Follow-up on 2% and 3% topical minoxidil | Regrowth peaked at one year then declined slowly, but at 5 years was still above baseline |
| Penha et al., 2024 | 68 men who completed, 24 weeks | Oral minoxidil vs 5% solution | Oral was not superior on the main outcome; somewhat better at the crown on photos |
In men, the most-cited trial compared 5% with 2% and placebo over 48 weeks: 5% was clearly superior, with 45% more regrowth than 2% and an earlier response (Olsen et al., 2002).
In women, 5% beat placebo on every primary measure, with more itching and facial hair than 2% (Lucky et al., 2004). It's worth investigating the cause before starting: hormones, thyroid or iron can produce similar-looking hair loss.
Over the long term, the most honest data point comes from a five-year follow-up: regrowth peaked around the first year and then declined slowly, although at five years the men still had more hair than when they started (Olsen et al., 1990). In other words, minoxidil doesn't stop the clock; it sets it back.
How it's used: solution, foam and consistency
How you apply it is set by your doctor and the product instructions. What we can explain is how it was used in the studies and what tends to make the difference:
- On the scalp, not on the hair. It goes on the skin of the thinning area, with the scalp dry, and is left on. Wash your hands afterwards.
- Solution or foam. In the trials, the solution was applied twice a day. The 5% foam contains no propylene glycol, a solvent that irritates some people, and in women it was tested once a day with results equivalent to 2% solution twice a day (Blume-Peytavi et al., 2011). In men, 5% foam also beat placebo (Olsen et al., 2007).
- Every day. The weak point of topical minoxidil isn't the drug, it's consistency. Frequently skipped applications are one of the most common reasons it "didn't work".
- More is not better. Using more, or more often, than directed doesn't speed anything up and does increase irritation and hair on the forehead or face.
The early shedding
Many patients notice more hair falling out in the first few weeks. Dermatologists describe this often, and it fits how the drug works: minoxidil shortens the resting phase and pushes those follicles into a new cycle, so the old hair comes out earlier to make way for the new one. It is usually temporary. If it's heavy or drags on, check with your doctor, but don't take it as a sign the treatment is harming you.
How long it takes
Trials measure the effect at 4 months and, above all, at one year. In practice:
| When | What to expect |
|---|---|
| Weeks 2 to 8 | Possibly more shedding than usual |
| Months 3 to 4 | First changes: less shedding, slightly thicker hair |
| Months 6 to 12 | The right time to judge, with comparable photos |
| After the first year | Maintenance: the effect holds while you keep using it |
Take photos in the same light and from the same angle every three months; the daily mirror is no way to judge a slow treatment.
Side effects of topical minoxidil
- Itching, flaking and irritation. The most common, and they increase with concentration (Olsen et al., 2002). The propylene glycol-free foam is usually better tolerated.
- Unwanted hair (forehead, cheeks), especially in women and with 5%. It usually improves when application is adjusted or stopped.
- Contact allergy. Uncommon. A review of patch-test-confirmed cases found the most common allergen was minoxidil itself (74.7%), followed by propylene glycol (17.1%) (Kiratiwongwan et al., 2025). If you get persistent redness, eczema or burning, stop and get it checked.
- Pregnancy and breastfeeding: not recommended. Talk to your doctor.
Oral minoxidil: what it is and what the evidence says
In recent years some dermatologists have started using low-dose oral minoxidil, well below the doses once used for blood pressure. It is an off-label use: the drug isn't approved for hair in this form, and a physician prescribes it after assessing the patient.
Effectiveness. In the only double-blind trial that compared it directly with 5% solution in men, oral minoxidil was not superior on the main outcome at 24 weeks; on photographic assessment it did somewhat better at the crown. The most common side effect was increased body hair (Penha et al., 2024).
Safety. The largest published series, 1,404 patients treated with low doses, found excess hair growth to be the most frequent effect (15.1%), with infrequent systemic effects such as lightheadedness (1.7%), fluid retention (1.3%) and tachycardia (0.9%); only 1.7% stopped because of side effects (Vañó-Galván et al., 2021). It is a retrospective study with no comparison group.
What you shouldn't do is split blood-pressure minoxidil tablets on your own. It lowers blood pressure and raises heart rate; anyone with heart problems, low blood pressure or other blood-pressure medication needs an assessment first. The dose, if it applies, is your doctor's call.
In practice: oral minoxidil is an alternative for people who can't tolerate the solution or can't use it consistently, not a shortcut to "more results". The convenience comes with systemic effects the topical doesn't have.
Why it doesn't work for some people
There are three main reasons:
- There's no follicle to stimulate. The most common one. If the area has been smooth for years, minoxidil has nothing to act on.
- Irregular use or quitting early. You can't judge it before 6 months, and skipped applications reduce the effect.
- Biological differences. Minoxidil is activated inside the follicle by an enzyme, sulfotransferase, whose activity varies from person to person. In a small study of 41 patients on oral minoxidil, those with low enzyme activity responded better than those with high activity (85% vs 43%), and men responded more often than women (Jimenez-Cauhe et al., 2024). This is preliminary; there is no routine test yet that predicts who will respond.
And a fourth: minoxidil can't make up for a cause that isn't androgenetic alopecia. Hair loss from stress, thyroid problems, anemia or a medication is treated differently.
When minoxidil is no longer enough
Minoxidil is a good treatment for maintaining and thickening the hair you still have. It doesn't replace hair that's gone. These are the signs you need something else:
| Your situation | What usually makes sense |
|---|---|
| Thinner hair, no smooth areas | Minoxidil, with or without a DHT blocker; reassess at 6 to 12 months |
| You've used minoxidil consistently for a year and loss keeps progressing | Review the plan with your doctor; often the DHT blocker is missing |
| Temples or crown already smooth | A hair transplant for those areas, plus medical therapy to protect the rest |
| You can't tolerate the solution or the foam | Talk to your doctor about alternatives, including oral minoxidil |
| You're a woman with diffuse thinning | Investigate the cause first; minoxidil is a common option; a transplant only in selected cases |
A hair transplant takes follicles from the back of the head, which are resistant to DHT, and places them where hair is missing; that hair doesn't depend on minoxidil. What it doesn't do is protect the native hair around it, which is why many patients stay on medical therapy after surgery. If you have a transplant, your surgeon will tell you whether to continue minoxidil and when to restart it.
If you're wondering whether to combine minoxidil with a DHT blocker, our guide to the real side effects of finasteride covers how common they are and why we usually prefer dutasteride, after an assessment. And if you're being offered minoxidil mesotherapy or PRP sessions, read mesotherapy vs PRP vs hair transplant first.
For our hair transplant in Medellín the standard rate is $4,700 COP per graft (about US$1.40), beard included; for women it is $5,400 COP (US$1.50) and for afro-textured hair $5,400 COP (US$1.70) per graft. As a reference, a standard 2,000-graft case comes to $9,400,000 COP (about US$2,800), with the figure confirmed in writing in your plan before surgery.
The bottom line
Minoxidil thickens and preserves hair that is weakening, especially at 5% and used daily for 6 to 12 months, and the gains hold while you keep using it. Low-dose oral minoxidil is an off-label alternative, only with a medical assessment. When the area is already smooth, minoxidil isn't enough: that's where a hair transplant brings hair back and medical therapy protects what's left.
If you'd like a physician to review whether minoxidil is working for you, whether it makes sense to add another treatment, or whether you're at the point of a transplant, book a free assessment.
Message us on WhatsApp and a physician will reply →
This article is for information only and does not replace a medical consultation. Don't start, change or stop any treatment without talking to your doctor.
Sources
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004. PMID 14996087
- Olsen EA, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002. PMID 12196747
- Lucky AW, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004. PMID 15034503
- Olsen EA, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007. PMID 17761356
- Blume-Peytavi U, et al. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011. PMID 21700360
- Olsen EA, et al. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol. 1990. PMID 2180995
- Kiratiwongwan R, et al. Allergic contact dermatitis to topical preparations containing minoxidil: a systematic review and individual participant data meta-analysis. Dermatitis. 2025. PMID 38885151
- Penha MA, et al. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol. 2024. PMID 38598226
- Vañó-Galván S, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021. PMID 33639244
- Jimenez-Cauhe J, et al. Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia. J Cosmet Dermatol. 2024. PMID 39034734